Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$6.63 +0.08 (+1.22%)
As of 07/25/2025 04:00 PM Eastern

ACB vs. THCX, CRON, GUD, TLRY, FIRE, WEED, OGI, EPI, ICC, and CPH

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Supreme Cannabis (FIRE), Canopy Growth (WEED), Organigram (OGI), ESSA Pharma (EPI), ICC Labs (ICC), and Cipher Pharmaceuticals (CPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$195.83M1.85-C$44.16M-C$0.81-8.19
HydropothecaryN/AN/AN/AN/AN/A

In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Aurora Cannabis Neutral
Hydropothecary Neutral

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
Hydropothecary N/A N/A N/A

13.4% of Aurora Cannabis shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Aurora Cannabis currently has a consensus target price of C$8.75, suggesting a potential upside of 31.98%. Given Aurora Cannabis' stronger consensus rating and higher probable upside, equities research analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Aurora Cannabis beats Hydropothecary on 5 of the 8 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$362.72MC$2.18BC$5.74BC$6.31B
Dividend YieldN/A2.92%4.69%6.72%
P/E Ratio-8.194.2328.4175.38
Price / Sales1.85587.23391.881,359.95
Price / Cash1.2510.3536.1883.29
Price / Book0.6011.038.654.89
Net Income-C$44.16MC$21.15BC$3.25BC$301.20M
7 Day Performance6.59%1.91%4.30%1.19%
1 Month Performance16.11%6.12%11.60%5.18%
1 Year Performance-18.85%3.01%35.38%25.79%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.7287 of 5 stars
C$6.63
+1.2%
C$8.75
+32.0%
-18.8%C$362.72MC$195.83M-8.191,073
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.84
+3.3%
N/A-16.9%C$749.94MC$76.86M-15.80450
GUD
Knight Therapeutics
N/AC$6.00
-0.8%
C$7.15
+19.2%
+7.7%C$606.90MC$348.70M-20.03725
TLRY
Tilray Brands
N/AC$0.91
+7.1%
N/A-63.0%C$586.37MC$610.34M-2.202,650News Coverage
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
WEED
Canopy Growth
1.3777 of 5 stars
C$1.54
+3.4%
C$2.20
+42.9%
-84.5%C$247.74MC$519.68M-0.222,700
OGI
Organigram
2.3292 of 5 stars
C$1.99
-1.0%
C$3.33
+67.1%
-8.4%C$245.85MC$180.58M-4.21987News Coverage
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up
CPH
Cipher Pharmaceuticals
1.3726 of 5 stars
C$12.42
+0.7%
C$14.75
+18.8%
+43.5%C$222.98MC$19.03M13.725News Coverage

Related Companies and Tools


This page (TSE:ACB) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners